ModivCare Inc header image

ModivCare Inc

MODV

Equity

ISIN US60783X1046 / Valor 59168951

NASDAQ (2024-11-20)
USD 16.31+4.62%

ModivCare Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

ModivCare Inc, formerly known as LogistiCare Solutions, LLC, is a company that focuses on providing non-emergency medical transportation services to individuals who require assistance in getting to and from medical appointments. The company ensures compliance with applicable Federal civil rights laws and offers free language interpreter services to individuals whose primary language is not English. ModivCare aims to eliminate discrimination based on race, color, national origin, age, disability, or sex in the provision of its services.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Revenue Growth

For the first quarter of 2024, ModivCare Inc. reported revenue of $684.5 million, marking a 3.3% increase from $662.3 million in the first quarter of 2023. This growth was driven by increases across its NEMT, PCS, and RPM segments.

Net Loss

ModivCare Inc. experienced a net loss of $22.3 million, or $1.57 per diluted common share, in the first quarter of 2024. This is a significant increase from the net loss of $4.0 million, or $0.28 per diluted common share, reported in the same period of the previous year.

Adjusted EBITDA

Adjusted EBITDA for ModivCare Inc. in the first quarter of 2024 was $32.1 million, or 4.7% of revenue. This represents a decrease from $50.2 million, or 7.6% of revenue, in the first quarter of 2023, primarily due to higher service expenses.

Cash Flow

During the first quarter of 2024, ModivCare Inc. generated $9.6 million in cash from operations, compared to $2.7 million used in operations during the same period in 2023. This improvement was influenced by changes in operating assets and liabilities, including contract receivables and payables.

Guidance

ModivCare Inc. maintained its revenue and adjusted EBITDA guidance for the fiscal year 2024, projecting revenue between $2,700 million and $2,900 million and adjusted EBITDA between $190 million and $210 million. This guidance excludes the effects of any future merger or acquisition activity.

Summarized from source with an LLMView Source

Key figures

-60.3%1Y
-89.0%3Y
-73.4%5Y

Performance

124%1Y
85.6%3Y
73.3%5Y

Volatility

Market cap

666 M

Market cap (USD)

Daily traded volume (Shares)

45,344

Daily traded volume (Shares)

1 day high/low

15.76 / 15.41

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Strategic Education Inc
Strategic Education Inc Strategic Education Inc Valor: 42985312
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.70%USD 95.52
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.85%USD 37.48
TransMedics Group Inc
TransMedics Group Inc TransMedics Group Inc Valor: 47361695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.90%USD 77.20
Supernus Pharmaceuticals Inc
Supernus Pharmaceuticals Inc Supernus Pharmaceuticals Inc Valor: 18393960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.66%USD 36.12
Ensign Group Inc
Ensign Group Inc Ensign Group Inc Valor: 3109721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 144.66
Krystal Biotech Inc
Krystal Biotech Inc Krystal Biotech Inc Valor: 38026052
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.14%USD 178.10
Mochida Seiyaku KK
Mochida Seiyaku KK Mochida Seiyaku KK Valor: 762797
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.95%JPY 3,260.00
Sotera Health Company
Sotera Health Company Sotera Health Company Valor: 57897071
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.94%USD 13.21
ICU Medical Inc
ICU Medical Inc ICU Medical Inc Valor: 940704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.24%USD 167.59
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.35%EUR 26.32